{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "DecreaseAmount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "hmdb:HMDB06564",
      "entity_text" : "glucose",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0079" ],
      "Species" : [ "taxonomy:59837" ]
    }
  },
  "verbose_text" : "So, can a combination of a GLUT isoform specific inhibitor (that would tend to raise blood glucose) plus a phloridzin like compound (to increase renal loss of glucose) be useful in cancer treatment?",
  "reading_complete" : "2020-08-08T15:50:20Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T15:39:51Z",
  "trigger" : "loss",
  "evidence" : [ "loss of glucose" ],
  "pmc_id" : "6243331",
  "score" : 0
}